Ishwaria M. Subbiah

The state of the oncologist workforce in America in areas prone to natural disasters.

Cannabis and Cannabinoids in Adults With Cancer: ASCO Guideline

Does exposure matter? Association between exposure to clinical trial conduct during training and intent to participate in clinical trials post-training among oncology fellows: An ASCO State of Cancer Care in America study.

Practical Assessment and Management of Vulnerabilities in Older Patients Receiving Systemic Cancer Therapy: ASCO Guideline Update

Everolimus in combination with vandetanib in children, adolescents, and young adults: a phase I study

The Evolution of Geriatric Oncology and Geriatric Assessment over the Past Decade

NCCN Guidelines® Insights: Older Adult Oncology, Version 1.2021

COVID-19 vaccine guidance for patients with cancer participating in oncology clinical trials

Association Between Health-Related Quality of Life and Progression-Free Survival in Patients With Advanced Cancer: A Secondary Analysis of SWOG Clinical Trials

Code status and outcomes in patients with cancer and COVID-19: A COVID-19 and cancer consortium (CCC19) registry analysis.

Cancer-related cognitive impairment in patients with non-central nervous system malignancies: an overview for oncology providers from the MASCC Neurological Complications Study Group

Progression-free survival is a suboptimal predictor for overall survival among metastatic solid tumour clinical trials

Performance Status Restriction in Phase III Cancer Clinical Trials

Integration of geriatric assessment into routine oncologic care and advances in geriatric oncology: A young International Society of Geriatric Oncology Report of the 2020 American Society of Clinical Oncology (ASCO) annual meeting

Biological predictors of chemotherapy-induced peripheral neuropathy (CIPN): MASCC neurological complications working group overview

Prognostic Indicators and Treatment Outcome in 94 Cases of Fibrolamellar Hepatocellular Carcinoma